Ligands and methods for preparing same

Details Ligands and methods for preparing same Ligands and methods for preparing same

2006-12-26

2006-12-26

Epperson, Jon (Department: 1639)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S415000, C514S419000, C435S004000, C435S007100, C548S490000

Reexamination Certificate

active

07153977

ABSTRACT:
A process is disclosed for modifying a parent ligand by attaching to the parent ligand a conjugation agent that is reactive with a moiety of a target receptor to which the parent ligand binds such that a covalent bond is formable between the conjugation agent and the receptor moiety. Also disclosed are compositions, probes and methods of detecting and/or quantifying receptors using the modified ligands of the invention.

REFERENCES:
patent: 4366241 (1982-12-01), Tom et al.
patent: 4843000 (1989-06-01), Litman et al.
patent: 4849338 (1989-07-01), Litman et al.
patent: 4879220 (1989-11-01), Mrsny et al.
patent: 4966891 (1990-10-01), Fujiu et al.
patent: 5134071 (1992-07-01), Gaetjens
patent: 5227487 (1993-07-01), Haugland et al.
patent: 5274113 (1993-12-01), Kang et al.
patent: 5298508 (1994-03-01), Jacobson et al.
patent: 5326692 (1994-07-01), Brinkley et al.
patent: 5329028 (1994-07-01), Ashkenazi et al.
patent: 5367058 (1994-11-01), Pitner et al.
patent: 5405864 (1995-04-01), Broka
patent: 5405975 (1995-04-01), Kuhn et al.
patent: 5433896 (1995-07-01), Kang et al.
patent: 5442045 (1995-08-01), Haugland et al.
patent: 5451663 (1995-09-01), Kang et al.
patent: 5453517 (1995-09-01), Kuhn et al.
patent: 5459276 (1995-10-01), Kuhn et al.
patent: 5470948 (1995-11-01), Fahrenholz et al.
patent: 5516864 (1996-05-01), Kuhn et al.
patent: 5573909 (1996-11-01), Singer et al.
patent: 5648270 (1997-07-01), Kuhn et al.
patent: 5658940 (1997-08-01), Muller et al.
patent: 5688941 (1997-11-01), Cook et al.
patent: 5723218 (1998-03-01), Haugland et al.
patent: 5849482 (1998-12-01), Meyer, Jr. et al.
patent: 5998603 (1999-12-01), Cook et al.
patent: 6087502 (2000-07-01), Sato
patent: 6147195 (2000-11-01), Scherz et al.
patent: 6153737 (2000-11-01), Manoharan et al.
patent: 40 14540 (1991-11-01), None
patent: 0 306 943 (1989-03-01), None
patent: 0 490 434 (1992-06-01), None
patent: WO 90/11779 (1990-10-01), None
patent: WO 91/00289 (1991-01-01), None
patent: WO 93/06121 (1993-04-01), None
patent: WO 95/02604 (1995-01-01), None
patent: WO 97/10847 (1997-03-01), None
patent: WO 97/20563 (1997-06-01), None
patent: WO 98/03632 (1998-01-01), None
patent: WO 98/11437 (1998-03-01), None
patent: WO 99/64396 (1999-12-01), None
Erspamer, Vittorio (1966). “Occurrence of indolealkylamines in nature” Chapter 4, in Handbook of Experimental Pharmacology. Vol. XIX. 5-hydroxytryptamine and Related Indolealkylamines. Eichler and Farah, ed., Srpinger-Verlag: Berlin, pp. 132-181.
Agbanyo, Francisca R. et al. (1990). “5′-S-(2-aminoethyl)-N6-(4-nitrobenzyl)-5′-thioadenosine (SAENTA), a novel ligand with high affinity for polypeptides associated with nucleoside transport”Biochem. J.270:605-614.
Baindur, Nandkishore and Neumeyer, John L. (1998). “A photoaffinity label for the D-1 dopamine receptor, (RS)-7[125I]iodo-8-hydroxy-3-methyl-1-(4′-azido-phenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine, selectively identifies the ligand binding subunits of the receptor”J. Med. Chem.31:2069-2071.
Beasley, Charles M. et al. (1992). “Fluoxetine: a review of receptor and functional effects and their clinical implications”Psychopharmacology107:1-10.
Belt, Judith A. (1983). “Nitrobenzylthioinosine-insensitive uridine transport in human lymphoblastoid and murine leukemia cells”Biochem. Biophys. Res. Commun.110(2):417-423.
Belt, Judith A. (1983). “Heterogeneity of nucleoside transport in mammalian cells. Two types of transport activity in L1210 and other cultured neoplastic cells”Mol. Pharmacol.24:479-484.
Belt, Judith A. and Noel, L. Diane (1985). “Nucleoside transport in Walker 256 rat carcinosarcoma and S49 mouse lymphoma cells”Biochem. J.232:681-688.
Bolden-Watson, C., and Richelson, E. (1993). “Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes”Life Sciences52:1023-1029.
Boyd, N.D. et al. (1991). “Photoaffinity labeling the substance P receptor using a derivative of substance P containing p-benzoylphenylalanine”Biochemistry30:336-342.
Burgermeister, Wolfgang et al. (1982). “Photoaffinity labeling of the β-adrenergic receptor with azide derivatives of iodocyanopindolol”J. Biol. Chem.257(8):5306-5311.
Cowen, P. J. and Anderson, I.M. (1991). “Abnormal 5-HT neuroendocrine function in depression: association or artifact?” Chapter 11in 5-Hydroxytryptamine in Psychiatry. Sandler et al. eds., Oxford University Press: New York, pp. 124-142.
Crawford, Charles R. et al. (1998). “Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transportereiby functional expression in a transport-deficient cell line”J. Biol. Chem.273(9):5288-5293.
Curtin, N.J. et al. (1999). “Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced α1-acid glycoprotein binding”Brit. J. Cancer80(11):1738-1746.
Dallery, Nathalie et al. (1993). “Purification and functional chaeacterization of the ligand-binding domain from the retinoic acid receptor α: Evidence that sulfhydryl groups are involved in ligand-receptor interactions”Biochemistry32:12428-12436.
Decristoforo, Clemens and Mather, Stephen J. (1999). “Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence”Eur. J. Nucl. Med.26(8):869-876.
Derkach, V. et al. (1989). “5-HT3receptors are membrane ion channels”Nature339:706-709.
Ehlert, Frederick J. and Griffin, Michael T. (1998). “The use of irreversible ligands to inactivate receptor subtypes: 4-DAMP mustard and muscarinic receptors in smooth muscle”Life Sciences62(17/18):1659-1664.
Emerit, M.B. et al. (1985). “Irreversible blockade of central 5-HT binding sites by 8-methoxy-2′-chloro-pat”Biochemical Pharmacology34(6):883-892.
Emerit, M.B. et al. (1986). “Irreversible blockade of central 5-HT1Areceptor binding sites by the photoaffinity probe 8-methoxy-3′-NAP-amino-PAT”Eur. J. Pharm.127:67-81.
Emerit, M.B. et al. (1987). “Identification of the 5-HT1Areceptor binding subunit in rat brain membranes using the photoaffinity probe [3H]8-methoxy-2-[N-n-propyl, N-3-(2-nitro-4-azidophenyl)aminopropyl]aminotetralin”J. Neurochem.49(2):373-380.
Erspamer, Vittorio (1966). “Occurrence of idolealkylamines in nature” Chapter 4in Handbook of Experimental Pharmacology. Vol. XIX. 5-Hydroxytryptamine and Related Indolealkylamines. Eichler and Farah, eds., Springer-Verlag: Berlin, pp. 132-181.
Fancy, David A. et al. (1996). “New chemistry for the study of multiprotein complexes: the six-histidine tag as a receptor for a protein crosslinking reagent”Chem.&Biol.3(7):551-559.
Gati, W.P. et al. (1983). “Interaction of 2′-halogeno-2′-deoxyuridines with the human erythrocyte nucleoside transport mechanism”Mol. Pharmacol.23:146-152.
Gati, Wendy P. et al. (1987). “[125I]Iodohydroxynitrobenzylthioinosine: a new high-affinity nucleoside transporter probe”Biochem. Cell Biol.65:467-473.
Goh, Lay-Beng et al. (1995). “Nitrobenzylthioinosine-binding protein overexpression in human breast, liver, stomach and colorectal tumour tissues”Anticancer Res.15:2575-2579.
Gozlan, H. et al. (1987). “Photoaffinity labelling and solubilization of the central 5-HT1Areceptor binding site”J. Receptor Res.7(1-4):195-221.
Griffith, Douglas A. and Jarvis, Simon M. (1996). “Nucleoside and nucleobase transport systems of mammalian cells”Biochim. Biophys. Acta1286:153-181.
He, Xiaolan et al. (1995). “High-yield affinity alkylation of the atrial natriuretic factor receptor binding site”Bioconjugate Chem.6:541-548.
Isambert, Marie-Francoise et al. (1998). “Photoaffinity labeling of the monoamine transporter of bovine chromaffin granules and other monoamine storage vesicles using 7-azido-8-[125

Affiliated with

Also associated with

Rating

Ligands and methods for preparing same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ligands and methods for preparing same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ligands and methods for preparing same will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3708188